Evolutionary aspect of Miltefosine transporter proteins in Leishmania major

Area of Science:

• Molecular Biology
• Parasitology
• Evolutionary Biology

Background:

• Miltefosine is a key drug against Leishmania major infections.
• Transporter proteins, including P-glycoprotein (P-gp) and P4ATPase-CDC50, mediate Miltefosine transport across cell membranes.
• Drug resistance in Leishmania major can arise from mutations or altered activity of these transporter proteins.

Purpose of the Study:

• To investigate the evolutionary divergence of Miltefosine transporter proteins (P-gp, P4ATPase, CDC50).
• To compare these transporters across diverse life forms, including Protists, Fungi, Plants, and Animals.
• To identify structural and functional differences between host and parasite transporters for targeted drug development.

Main Methods:

• Sequence retrieval of P-gp, P4ATPase, and CDC50 proteins from various organisms (96, 207, and 189 sequences, respectively).
• Phylogenetic tree construction using Bayesian posterior probability inference.
• Comparative analysis of conserved regions and variations within transporter protein families.

Main Results:

• Miltefosine transporter proteins (P-gp, P4ATPase, CDC50) are highly conserved across diverse species.
• Significant structural and functional differences were observed between human (host) and Leishmania major (parasite) transporter proteins.
• Phylogenetic patterns highlight conserved and variable regions, providing insights into protein function.

Conclusions:

• The conserved nature of these transporters suggests essential roles across species.
• Identified host-parasite specific differences in Miltefosine transporters are key for developing targeted antiparasitic therapies.
• Understanding evolutionary divergence aids in designing more effective and specific drugs against Leishmania major.